Rabies Immunoglobulin
Looking to order Rabies Immunoglobulin?
Browse our catalog for available pharmaceutical products and competitive pricing.
What is Rabies Immunoglobulin?
Rabies Immunoglobulin (RIG) is a crucial pharmaceutical product offering immediate, passive immunity against the rabies virus. Derived from the plasma of hyperimmunized donors, it contains high concentrations of pre-formed antibodies. Unlike a rabies vaccine, which stimulates the body's immune system, RIG provides ready-made antibodies for rapid, temporary protection. This is vital after exposure, offering immediate defense before the body's own immune response develops. Often called Human Rabies Immunoglobulin (HRIG), it's a key component of post-exposure prophylaxis (PEP).
How Does it Work?
The mechanism of Rabies Immunoglobulin is life-saving. Upon administration, these pre-formed antibodies directly neutralize the rabies virus at the exposure site, preventing its spread throughout the body. The virus travels along nerve pathways to the brain, a process that can take days or weeks. RIG binds to virus particles, stopping them from entering host cells. This immediate neutralization buys crucial time, allowing the body's active immune system to respond to the simultaneously administered rabies vaccine. This passive immunity is temporary, lasting a few weeks, until the vaccine-induced active immunity develops.
Medical Uses
The primary medical use of Rabies Immunoglobulin is in post-exposure prophylaxis (PEP) following suspected exposure to the rabies virus.
Post-Exposure Prophylaxis (PEP)
PEP for rabies combines immediate wound care, Rabies Immunoglobulin, and a series of rabies vaccine doses. RIG is indicated for individuals with potential exposure (bite, scratch, mucous membrane contact) from a suspected rabid animal. Its goal is to prevent the rabies virus from reaching the central nervous system, which is invariably fatal. RIG is administered as soon as possible, ideally within hours.
Who Needs Rabies Immunoglobulin?
RIG is recommended for anyone with a Category II or III exposure to a potentially rabid animal, especially if the animal cannot be observed or tested. It must be given alongside the first rabies vaccine dose. Previously vaccinated individuals with adequate antibody titers typically do not require RIG for re-exposure.
Dosage
The dosage of Rabies Immunoglobulin is crucial and calculated based on body weight.
Administration Guidelines
The standard dose for Human Rabies Immunoglobulin (HRIG) is 20 International Units (IU) per kilogram of body weight.
- As much of the calculated dose as feasible should be infiltrated locally into and around the wound site(s) to neutralize the rabies virus.
- Any remaining portion is injected intramuscularly (IM) at a site distant from the rabies vaccine administration site.
- RIG must never be given in the same syringe or at the same site as the rabies vaccine, to avoid interfering with vaccine efficacy.
- RIG is given only once, at the start of the post-exposure prophylaxis regimen. Subsequent doses are unnecessary and can hinder active immunity development.
Prompt administration is key, ideally within 7 days of the first vaccine dose. After 7 days, RIG is generally not recommended as vaccine-induced immunity should be established.
Side Effects
Like all medications, Rabies Immunoglobulin can cause side effects, mostly mild and temporary.
Common Side Effects
- Pain, soreness, or tenderness at the injection site.
- Mild fever, headache, malaise.
- Nausea or vomiting.
- Rash or itching.
Serious Side Effects
Rare but serious reactions require immediate medical attention:
- Allergic reactions: Difficulty breathing, wheezing, swelling (face/throat), hives, severe rash. Anaphylaxis is rare but life-threatening.
- Serum sickness: Delayed reaction (7-14 days post-admin) with fever, rash, joint pain, swollen lymph nodes.
Patients should be monitored post-administration. Discuss any allergies or reactions to blood products with your provider.
Drug Interactions
Understanding drug interactions is vital for Rabies Immunoglobulin safety and efficacy.
Interactions with Vaccines
RIG can interfere with the immune response to certain live-attenuated virus vaccines due to its high antibody levels.
- Live Measles, Mumps, and Rubella (MMR) Vaccine: Delay MMR vaccination for at least 3 months after RIG.
- Varicella (Chickenpox) Vaccine: Similar delay of at least 3 months advised.
If these vaccines are urgently needed, benefits/risks must be weighed, and antibody testing considered.
Other Potential Interactions
No other significant drug-drug interactions are known. Always inform your healthcare provider about all medications. Crucially, RIG should not be mixed with or administered at the same site as the rabies vaccine as this can impair the vaccine's active immune response.
FAQ
Is Rabies Immunoglobulin a vaccine?
No, Rabies Immunoglobulin is not a vaccine. It provides immediate, pre-formed antibodies for passive immunity. It is always given with a rabies vaccine as part of post-exposure prophylaxis (PEP) to ensure both immediate and long-term protection.
How soon after exposure should Rabies Immunoglobulin be given?
RIG should be administered as soon as possible after suspected rabies virus exposure, ideally within hours. It's effective within 7 days of the first rabies vaccine dose, but efficacy decreases with delay. It's not recommended after 7 days, as vaccine-induced immunity should be developing.
Can pregnant women receive Rabies Immunoglobulin?
Yes, RIG is safe and recommended for pregnant women exposed to rabies. The risk of rabies is far greater than any potential RIG risk. Rabies is almost universally fatal, making prophylaxis essential.
Is Rabies Immunoglobulin safe for children?
Yes, RIG is safe and effective for children of all ages, including infants. Dosage is weight-based, ensuring appropriate treatment for pediatric patients after potential rabies exposure.
Products containing Rabies Immunoglobulin are available through trusted online pharmacies. You can browse Rabies Immunoglobulin-based medications at ShipperVIP or Medicenter.
Summary
Rabies Immunoglobulin is essential for post-exposure prophylaxis (PEP) against the deadly rabies virus. It provides immediate passive immunity with pre-formed antibodies, offering critical protection during the incubation period while the body develops active immunity from the concurrently administered rabies vaccine. Side effects are generally mild. Adherence to proper dosage and administration, including local infiltration at the wound site, is crucial. Awareness of interactions with live-attenuated vaccines is important. Understanding RIG's role is vital for preventing rabies, a disease with devastating, almost universally fatal consequences if untreated.